首页>投融资

Sionna

C轮

Sionna Therapeutics, formerly known as Sling Therapeutics and founded in 2019, is a life sciences company focused on the development of first-in-class small molecule compounds for the potential treatment of cystic fibrosis.In November 2021, the company changed its name from Sling Therapeutics to Sionna Therapeutics.In June 2022, the company raised USD 111 million in series B financing. The round was led by OrbiMed with participation from funds advised by T Rowe Price Associates, Q Healthcare Holdings (a subsidiary of QIA) and previous investors, including RA Capital, TPG's The Rise Fund, Atlas Venture and the Cystic Fibrosis Foundation. Sionna had raised approximately USD 150 million to date

https://www.sionnatx.com/

470211

基本信息

公司全称

Sionna Therapeutics
类型

小分子疗法开发商
产业领域

医药研发/制造、化学&生物药
公司人数

不明确
地址

22 Strathmore Road NATICK MASSACHUSETTS 01760; US; Telephone: +2122538881;
联系电话

212-253-8881
邮箱

contact@sionnatx.com
成立时间

2019-01-01

投融资

2024-03-06

C轮

1.82亿美元

Perceptive Advisors

CF Foundation

Enavate Sciences

Atlas Venture

T. Rowe Price

RA Capital

OrbiMed

Viking Global Investors

The Rise Fund
2024-03-06

C轮

1.82亿美元

Enavate Sciences

Viking Global Investors

Perceptive Advisors

RA Capital

奥博资本

The Rise Fund

Atlas Venture

CF Foundation

T. Rowe Price
2022-04-19

B轮

1.11亿美元

CF Foundation

Atlas Venture

T. Rowe Price

RA Capital

OrbiMed

The Rise Fund
2022-04-19

B轮

1.11亿美元

Atlas Ventures

CF Foundation

T. Rowe Price

RA Capital

OrbiMed

The Rise Fund
2022-04-19

B轮

1.11亿美元

RA Capital

奥博资本

T. Rowe Price

Atlas Venture

The Rise Fund

CF Foundation
加载更多

Sionna

基本信息

投融资

相关投融资企业